Amylase 2A conjugated to a Fab fragment of human IgG1 (Valerion Therapeutics/University of Kentucky)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameAmylase 2A conjugated to a Fab fragment of human IgG1 (Valerion Therapeutics/University of Kentucky)
Drug Alias NameFab-AMY (Valerion Therapeutics/University of Kentucky)
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Enzyme
Mechanisms of ActionEnzymes stimulants
TargetsEnzymes
Therapy Area/IndicationsLafora Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesValerion Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesValerion Therapeutics LlcUniversity Of Kentucky
Active IndicationsN/A
Inactive IndicationsLafora Disease

Other Information

ATC CodeN/A
Related LinksN/A